Min-horn Tsai
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Comparison of the efficacy of 14-day sequential therapy and 10-day bismuth quadruple therapy in the second line therapy for Helicobacter pylori infection- A multi-center randomized trial.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: January 02, 2026
Impact of glucose-containing fluid on acute pancreatitis outcomes: A multicenter retrospective analysis.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: November 24, 2023
Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials.
Journal: The lancet. Gastroenterology & hepatology
Published: January 19, 2023
Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial.
Journal: The lancet. Gastroenterology & hepatology
Published: August 31, 2022
Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysis.
Journal: Helicobacter
Published: January 29, 2022
Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial.
Journal: Therapeutic advances in gastroenterology
Published: January 19, 2020
Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan.
Journal: Journal of gastroenterology and hepatology
Published: December 31, 2018
14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial.
Journal: The Journal of antimicrobial chemotherapy
Published: February 25, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026